Nutriband Inc (NTRB)

$4.00 -0.28 (-6.43%)
Market Cap 50.04M
Revenue (ttm) 2.14M
Net Income (ttm) -10.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 2.80
Profit Margin -489.72%
Debt to Equity Ratio 0.01
Volume 14,365
Avg Vol 35,618
Day's Range N/A - N/A
Shares Out 12.18M
Stochastic %K 53%
Beta 1.87
Analysts Sell
Price Target $15.00

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology
Sector: Healthcare
Phone: 407 377 6695
Address:
121 South Orange Avenue, Suite 1500, Orlando, United States
DipRider
DipRider Feb. 18 at 9:27 AM
$NTRB Neuropsychiatric biotech with data-dependent upside; timeline risk persists.
0 · Reply
Pacificstock27
Pacificstock27 Feb. 17 at 11:10 PM
$NTRB “Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and all sports tape products manufactured at its Pocono Pharmaceutical / Active Intell subsidiary. Innomedica will also be overseeing and financing all regulatory approvals for the above mentioned products as they ramp up for launch.” lets see launch news and fda updates!!
0 · Reply
birdmanCap
birdmanCap Feb. 17 at 8:48 PM
$NTRB
0 · Reply
NetworkNewsWire
NetworkNewsWire Feb. 17 at 2:32 PM
BioMedNewsBreaks — $NTRB Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products https://ibn.fm/lyOS9
0 · Reply
VoidGorilla
VoidGorilla Feb. 16 at 11:34 PM
3 $KITT $NTRB $UOKA $DOMH 3
0 · Reply
Covode13
Covode13 Feb. 16 at 8:39 PM
$NTRB 💩
0 · Reply
NNTrader
NNTrader Feb. 14 at 8:06 PM
$NTRB Nutriband terminated a previously agreed-to sale of its subsidiary Pocono Pharmaceuticals to Earth Vision Bio. Nutriband said Earth Vision failed to pay applicable late fees for not closing the deal by the end of 2025.
0 · Reply
Pacificstock27
Pacificstock27 Feb. 13 at 1:20 PM
$NTRB Lets see this uptrend
0 · Reply
RiccoTheGreat2
RiccoTheGreat2 Feb. 12 at 8:01 PM
$NTRB Da fuck??!!! Patience is wearing thin
2 · Reply
BullInvest
BullInvest Feb. 10 at 12:56 AM
$NTRB damn pt $16. Filed with FINRA to check on naked short selling… future looking bright
0 · Reply
Latest News on NTRB
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

Feb 17, 2026, 7:28 AM EST - 1 day ago

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

NTRBW

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

Jan 30, 2026, 7:00 AM EST - 19 days ago

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

NTRBW

Nutriband CEO Publishes Letter to Shareholders

Dec 31, 2025, 7:00 AM EST - 7 weeks ago

Nutriband CEO Publishes Letter to Shareholders

NTRBW

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Dec 29, 2025, 9:00 AM EST - 7 weeks ago

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

NTRBW

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Dec 18, 2025, 7:00 AM EST - 2 months ago

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

NTRBW

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

Nov 24, 2025, 7:00 AM EST - 3 months ago

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

NTRBW

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Oct 28, 2025, 11:05 AM EDT - 4 months ago

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Oct 28, 2025, 7:00 AM EDT - 4 months ago

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Oct 10, 2025, 7:00 AM EDT - 4 months ago

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

Oct 8, 2025, 8:30 AM EDT - 4 months ago

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

NTRBW

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

Oct 8, 2025, 6:30 AM EDT - 4 months ago

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

NTRBW

Nutriband Inc. to Present at the MicroCap Rodeo Conference

Sep 24, 2025, 4:05 PM EDT - 5 months ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

NTRBW

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Sep 10, 2025, 9:15 AM EDT - 5 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

NTRBW

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

Sep 3, 2025, 4:01 PM EDT - 6 months ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

NTRBW

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Aug 18, 2025, 9:00 AM EDT - 6 months ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Aug 11, 2025, 5:00 AM EDT - 6 months ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

NTRBW

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Aug 8, 2025, 8:00 AM EDT - 6 months ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Jul 18, 2025, 9:15 AM EDT - 7 months ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

NTRBW

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Jul 2, 2025, 8:05 AM EDT - 8 months ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

NTRBW

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

Jul 1, 2025, 7:00 AM EDT - 8 months ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

NTRBW

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Jun 9, 2025, 7:30 AM EDT - 9 months ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

NTRBW

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 11, 2025, 7:00 AM EDT - 11 months ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRBW

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Apr 4, 2025, 5:41 PM EDT - 11 months ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRBW

Nutriband Signs Partnership Agreement with Charlotte FC

Apr 4, 2025, 7:00 AM EDT - 11 months ago

Nutriband Signs Partnership Agreement with Charlotte FC

NTRBW

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 21, 2025, 7:00 AM EST - 1 year ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRBW

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 13, 2025, 7:00 AM EST - 1 year ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Feb 7, 2025, 8:45 AM EST - 1 year ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRBW

Nutriband Issues Letter to Shareholders

Dec 31, 2024, 7:00 AM EST - 1 year ago

Nutriband Issues Letter to Shareholders

NTRBW

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 27, 2024, 9:25 AM EST - 1 year ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRBW

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nov 27, 2024, 7:00 AM EST - 1 year ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRBW

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRBW

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRBW

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRBW

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRBW

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRBW

Nutriband Inc. Authorizes $1M Share Buyback Program

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRBW

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 19, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRBW

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRBW

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Jun 20, 2024, 7:00 AM EDT - 1 year ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRBW

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRBW

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

May 16, 2024, 7:00 AM EDT - 1 year ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRBW

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

May 10, 2024, 9:00 AM EDT - 1 year ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CANF

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

NTRBW

Nutriband Inc. Announces $8.4M Private Placement

Apr 19, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Announces $8.4M Private Placement

NTRBW

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 25, 2024, 7:00 AM EDT - 2 years ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 4, 2024, 7:00 AM EST - 2 years ago

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Jan 29, 2024, 7:00 AM EST - 2 years ago

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

NTRBW

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Nov 28, 2023, 7:00 AM EST - 2 years ago

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

NTRBW

DipRider
DipRider Feb. 18 at 9:27 AM
$NTRB Neuropsychiatric biotech with data-dependent upside; timeline risk persists.
0 · Reply
Pacificstock27
Pacificstock27 Feb. 17 at 11:10 PM
$NTRB “Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and all sports tape products manufactured at its Pocono Pharmaceutical / Active Intell subsidiary. Innomedica will also be overseeing and financing all regulatory approvals for the above mentioned products as they ramp up for launch.” lets see launch news and fda updates!!
0 · Reply
birdmanCap
birdmanCap Feb. 17 at 8:48 PM
$NTRB
0 · Reply
NetworkNewsWire
NetworkNewsWire Feb. 17 at 2:32 PM
BioMedNewsBreaks — $NTRB Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products https://ibn.fm/lyOS9
0 · Reply
VoidGorilla
VoidGorilla Feb. 16 at 11:34 PM
3 $KITT $NTRB $UOKA $DOMH 3
0 · Reply
Covode13
Covode13 Feb. 16 at 8:39 PM
$NTRB 💩
0 · Reply
NNTrader
NNTrader Feb. 14 at 8:06 PM
$NTRB Nutriband terminated a previously agreed-to sale of its subsidiary Pocono Pharmaceuticals to Earth Vision Bio. Nutriband said Earth Vision failed to pay applicable late fees for not closing the deal by the end of 2025.
0 · Reply
Pacificstock27
Pacificstock27 Feb. 13 at 1:20 PM
$NTRB Lets see this uptrend
0 · Reply
RiccoTheGreat2
RiccoTheGreat2 Feb. 12 at 8:01 PM
$NTRB Da fuck??!!! Patience is wearing thin
2 · Reply
BullInvest
BullInvest Feb. 10 at 12:56 AM
$NTRB damn pt $16. Filed with FINRA to check on naked short selling… future looking bright
0 · Reply
MomentumSpark
MomentumSpark Feb. 9 at 1:51 PM
$NTRB Biotech with binary clinical catalysts; valuation prone to drastic swings on data.
0 · Reply
tknighted1
tknighted1 Feb. 9 at 12:21 PM
$SMX Irish Times Reports on potential for "Naked Short Selling"; in stock 80% held by long term holders and insiders according the CEO Gareth Sheridan $NTRB https://www.marketbeat.com/instant-alerts/short-interest-in-nutriband-inc-nasdaqntrb-grows-by-227-2025-12-31/
0 · Reply
tknighted1
tknighted1 Feb. 9 at 12:15 PM
Irish Times Reports on potential for "Naked Short Selling" in stock 80% held by long term holders and insiders according the CEO Gareth Sheridan $NTRB https://www.marketbeat.com/instant-alerts/short-interest-in-nutriband-inc-nasdaqntrb-grows-by-227-2025-12-31/
0 · Reply
Master47
Master47 Feb. 8 at 4:01 PM
$NTRB 85.22% of volume = short selling. Virtually no organic selling by long holders. If this is accurate, price action ≠ fundamentals. Worth thinking about.
0 · Reply
Pacificstock27
Pacificstock27 Feb. 6 at 1:29 PM
$NTRB Ready for a green day pop back up
0 · Reply
Covode13
Covode13 Feb. 4 at 10:21 PM
$NTRB when will the FDA approval happen? This is insane for how long this crap takes. These shares given out are basically a waste!
0 · Reply
Pacificstock27
Pacificstock27 Feb. 4 at 6:24 PM
$NTRB Back down to $4.20 s. thought we can hit $5. Just need good news
0 · Reply
Pacificstock27
Pacificstock27 Feb. 4 at 4:19 PM
$NTRB Pop back to $5 s would be sweet.
0 · Reply
birdmanCap
birdmanCap Feb. 4 at 12:30 PM
$NTRB all the signs and chart would say this is due a pop back up to $6.50 +
0 · Reply
Covode13
Covode13 Feb. 2 at 11:08 PM
$NTRB
0 · Reply
NetworkNewsWire
NetworkNewsWire Jan. 30 at 3:47 PM
BioMedNewsBreaks — $NTRB $NTRBW Highlights Board Appointments and AVERSA Fentanyl Milestones From Annual Meeting https://ibn.fm/cp5lC
0 · Reply
Pacificstock27
Pacificstock27 Jan. 28 at 3:28 PM
$NTRB any good news and this can take off quickly with the low float.
0 · Reply